News from Economic Times Markets
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Stocks
Crypto Assets
Cryptocurrency
Investors
Shares
Stock
Stock Market
Ethereum
Price
Markets
Xrp
Blockchain
Investment
Sec
Etf
Stablecoin
Eth
Trade
Earnings
Index
Bse
Revenue
Solana
Ipo
China
Coinbase
Token
Wall Street
Nasdaq
Inflation
Interest Rates
Trade War
Usd
Economy
Sensex
Tesla
Profit
Digital Assets
Nse
Sp 500
Gold
Traders
Nvidia
Treasury
Federal Reserve
Vix
Corporate Bonds
Profit After Tax
National Energy System Operator
Golden Cross Pattern
Btc Pizza Day
Sovereign Crypto Reserves
Subscription Warrants
Scotia
Accredited Investor Rules
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search Economic Times Markets headlines…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Economic Times Markets • Jun 04, 2025
Sun Pharma Advanced Research shares tank 20% after psoriasis drug fails Phase 2 trials
The discontinuation of Vibozilimod development following unsuccessful Phase 2 results, combined with an unexpected FDA inspection, has led to a notable decline in Sun Pharma Advanc...
Read Full Article →